251
|
Wang L, Yan M, Wang Y, Lei G, Yu Y, Zhao C, Tang Z, Zhang G, Tang C, Yu J, Liao H. Proliferation and osteo/odontoblastic differentiation of stem cells from dental apical papilla in mineralization-inducing medium containing additional KH(2)PO(4). Cell Prolif 2013; 46:214-22. [PMID: 23510476 DOI: 10.1111/cpr.12016] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2012] [Accepted: 11/16/2012] [Indexed: 02/06/2023] Open
Abstract
OBJECTIVES Stem cells from the dental apical papilla (SCAPs) can be induced to differentiate along both osteoblast and odontoblast lineages. However, little knowledge is available concerning their differentiation efficiency in osteogenic media containing additional KH2 PO4 . MATERIALS AND METHODS Stem cells from the dental apical papilla were isolated from apical papillae of immature third molars and treated with two kinds of mineralization-inducing media, MM1 and MM2, differing in KH2 PO4 concentration. Proliferation and osteo/odontogenic differentiation capacity of MM1/MM2-treated SCAPs were investigated and compared both in vitro and in vivo. RESULTS Cell counting and flow cytometry demonstrated that MM2 containing 1.8 mm additional KH2 PO4 significantly enhanced proliferative potential of SCAPs, compared to MM1. Osteo/odontogenic capacity of SCAPs was much better in MM2 medium than in MM1, as indicated by elevated alkaline phosphatase activity, increased calcium deposition and upregulated expression of osteo/odontoblast-specific genes/proteins (for example, runt-related transcription factor 2, osterix, osteocalcin, dentin sialoprotein, and dentin sialophosphoprotein). In vivo transplantation findings proved that SCAPs in MM2 group generated more mineralized tissues, and presented higher expression of osteo/odontoblast-specific proteins (osteocalcin and dentin sialoprotein) than those in the MM1 group. CONCLUSION Mineralization-inducing media supplemented with 1.8 mm additional KH2 PO4 significantly enhanced cell proliferation and improved differentiation capacity of SCAPs along osteo/odontogenic cell lineages, compared to counterparts lacking additional KH2 PO4 .
Collapse
|
252
|
Yang Y, Luo L, Xu J, Zhu P, Xue W, Wang J, Li W, Wang M, Cheng K, Liu S, Tang Z, Ring BZ, Su L. Novel EDA p.Ile260Ser mutation linked to non-syndromic hypodontia. J Dent Res 2013; 92:500-6. [PMID: 23625373 DOI: 10.1177/0022034513487557] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Hypodontia, a tooth developmental disease, can affect chewing and pronunciation. Mutations in the ectodysplasin-A (EDA) gene can lead to both X-linked hypohidrotic ectodermal dysplasia (XLHED) and non-syndromic hypodontia (NSH). However, the mechanism by which these 2 related but different disorders are caused by the distinct mutations in EDA is unknown. In this study, we identified a novel missense mutation (c.779 T>G) in a Chinese family with NSH via a direct sequencing approach. This mutation results in an Ile260Ser substitution in the tumor necrosis factor (TNF) homology domain. Homology modeling suggests that this alteration may induce a conformational change in the hydrophobic center of the TNF homology domain. Furthermore, by exploring systematic 3D conformation analysis and calculation of residue relative solvent accessibility (RSA) for all the reported mutated amino acid sites on EDA's TNF homology domain, we found that the site mutations at the interior may be linked to XLHED, while those at the surface are more likely to be associated with NSH. These findings may aid in the discovery of unidentified functionally significant mutation sites in the EDA gene and provide a new way to clarify the mechanisms by which the XLHED and NSH phenotypes arise from mutations in the same gene.
Collapse
|
253
|
Chen J, Tang Z, Dong X, Gao S, Fang H, Wu D, Xiang D, Zhang S. Radiofrequency ablation for liver metastasis from gastric cancer. Eur J Surg Oncol 2013. [PMID: 23597495 DOI: 10.1016/j.ejso.2013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/30/2022] Open
Abstract
AIMS Several studies have reported the benefit of hepatic resection for metastatic tumor from gastric cancer. However, the value of treatment with radiofrequency ablation (RFA) has not been clearly defined. METHODS Between Jan 2002 and Dec 2007, 21 patients with primary gastric cancer were diagnosed with synchronous or metachronous liver metastases. All patients were treated with RFA, and the complication, survival, and recurrence rates were assessed. RESULTS The postoperative complication rate was 5% (1/21), with no mortality. The median actuarial survival time was 14 months. The 1-yr, 2-yr, 3-yr, and 5-yr survival rates after RFA were 70%, 11%, 5%, and 3%, respectively. With a median follow-up time of 19 months, local recurrence at the RFA site was 19% (4/21). Solitary metastasis had significantly longer survival than multiple lesions after RFA (22 vs 10 months, P = 0.004). CONCLUSIONS RFA provides a minimally invasive and safe modality of treatment patients with liver metastasis from gastric cancer. Patients with solitary liver lesion were considered appropriate candidates for RFA.
Collapse
|
254
|
Chen J, Tang Z, Dong X, Gao S, Fang H, Wu D, Xiang D, Zhang S. Radiofrequency ablation for liver metastasis from gastric cancer. Eur J Surg Oncol 2013; 39:701-6. [PMID: 23597495 DOI: 10.1016/j.ejso.2013.03.023] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2012] [Revised: 02/25/2013] [Accepted: 03/25/2013] [Indexed: 12/16/2022] Open
Abstract
AIMS Several studies have reported the benefit of hepatic resection for metastatic tumor from gastric cancer. However, the value of treatment with radiofrequency ablation (RFA) has not been clearly defined. METHODS Between Jan 2002 and Dec 2007, 21 patients with primary gastric cancer were diagnosed with synchronous or metachronous liver metastases. All patients were treated with RFA, and the complication, survival, and recurrence rates were assessed. RESULTS The postoperative complication rate was 5% (1/21), with no mortality. The median actuarial survival time was 14 months. The 1-yr, 2-yr, 3-yr, and 5-yr survival rates after RFA were 70%, 11%, 5%, and 3%, respectively. With a median follow-up time of 19 months, local recurrence at the RFA site was 19% (4/21). Solitary metastasis had significantly longer survival than multiple lesions after RFA (22 vs 10 months, P = 0.004). CONCLUSIONS RFA provides a minimally invasive and safe modality of treatment patients with liver metastasis from gastric cancer. Patients with solitary liver lesion were considered appropriate candidates for RFA.
Collapse
|
255
|
Adamczyk L, Adkins JK, Agakishiev G, Aggarwal MM, Ahammed Z, Alekseev I, Alford J, Anson CD, Aparin A, Arkhipkin D, Aschenauer E, Averichev GS, Balewski J, Banerjee A, Barnovska Z, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bhattarai P, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Brandin AV, Brovko SG, Bruna E, Bültmann S, Bunzarov I, Burton TP, Butterworth J, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chang Z, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Chwastowski J, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Das S, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derradi de Souza R, Dhamija S, di Ruzza B, Didenko L, Ding F, Dion A, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Eun L, Evdokimov O, Fatemi R, Fazio S, Fedorisin J, Fersch RG, Filip P, Finch E, Fisyak Y, Flores E, Gagliardi CA, Gangadharan DR, Garand D, Geurts F, Gibson A, Gliske S, Grebenyuk OG, Grosnick D, Gupta A, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Horvat S, Huang B, Huang HZ, Huck P, Humanic TJ, Igo G, Jacobs WW, Jena C, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kesich A, Kikola DP, Kiryluk J, Kisel I, Kisiel A, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kulakov I, Kumar L, Lamont MAC, Landgraf JM, Landry KD, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Luo X, Luszczak A, Ma GL, Ma YG, Madagodagettige Don DMMD, Mahapatra DP, Majka R, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Mondal MM, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nelson JM, Nogach LV, Novak J, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pan YX, Pandit Y, Panebratsev Y, Pawlak T, Pawlik B, Pei H, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Poljak N, Porter J, Poskanzer AM, Powell CB, Pruneau C, Pruthi NK, Przybycien M, Pujahari PR, Putschke J, Qiu H, Ramachandran S, Raniwala R, Raniwala S, Ray RL, Riley CK, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ross JF, Ruan L, Rusnak J, Sahoo NR, Sahu PK, Sakrejda I, Salur S, Sandacz A, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmidke B, Schmitz N, Schuster TR, Seger J, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma B, Sharma M, Shi SS, Shou QY, Sichtermann EP, Singaraju RN, Skoby MJ, Smirnov D, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Turnau J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Vossen A, Wada M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Wu YF, Xiao Z, Xie W, Xin K, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yi L, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhang JB, Zhang S, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y, Zyzak M. Observation of an energy-dependent difference in elliptic flow between particles and antiparticles in relativistic heavy ion collisions. PHYSICAL REVIEW LETTERS 2013; 110:142301. [PMID: 25166982 DOI: 10.1103/physrevlett.110.142301] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2013] [Indexed: 06/03/2023]
Abstract
Elliptic flow (v(2)) values for identified particles at midrapidity in Au + Au collisions, measured by the STAR experiment in the beam energy scan at RHIC at sqrt[s(NN)] = 7.7-62.4 GeV, are presented. A beam-energy-dependent difference of the values of v(2) between particles and corresponding antiparticles was observed. The difference increases with decreasing beam energy and is larger for baryons compared to mesons. This implies that, at lower energies, particles and antiparticles are not consistent with the universal number-of-constituent-quark scaling of v(2) that was observed at sqrt[s(NN)] = 200 GeV.
Collapse
|
256
|
Yin X, Yu B, Tang Z, He B, Ren J, Xiao X, Tang W. Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer. Cancer Gene Ther 2012; 20:77-81. [PMID: 23258087 DOI: 10.1038/cgt.2012.86] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Bladder cancer is the most common cancer in the urological tract. Here, we investigated the molecular pathways involved in the apoptosis of rodent bladder cancer, which was treated with Bifidobacterium infantis (BI)-mediated herpes simplex virus thymidine kinase (HSV-TK)/ganciclovir (GCV) suicide gene therapy. We engineered the BI-TK system, which consists of BI with the recombinant plasmid PGEX-1λT carrying HSV-TK (that is, TK) gene. Tumor-bearing rats were randomly divided into three groups and tail vein injected with normal saline (group A), BI/PGEX-1λT (group B) or BI-TK (group C), followed by intraperitoneal injection of GCV. The BI-TK/GCV system (group C) was shown to inhibit tumor growth and caused the apoptosis of tumor cells as assessed by in situ terminal transferase dUTP nick-end labeling assay. While varied extents of apoptosis were detected in tumor cells from all groups, tumor cells treated with BI-TK/GCV system (group C) exhibited the highest level of apoptosis (P < 0.05), consistent with our previous studies. Furthermore, we found that the expression levels of Fas, FasL, Cyt-C and caspase-9 in tumor tissues derived from group C were significantly higher than the other two groups (P < 0.001). Therefore, our results have demonstrated that the BI-TK/GCV therapy system exhibits a sustainable antitumor growth activity in the rodent model of bladder cancer. Mechanistically, both extrinsic and intrinsic apoptosis pathways are involved in the BI-TK/GCV antitumor functionality.
Collapse
|
257
|
Chiblak S, Campos B, Gal Z, Tang Z, Brons S, Unterberg A, Debus J, Herold-Mende C, Abdollahi A. Photon Versus Proton Versus Carbon Irradiation of Glioma Initiating Cells. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1809] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
258
|
Dai Y, Melzig C, Hanne J, Tang Z, Herfarth K, Debus J, Wei Q, Abdollahi A. Combined ALK-inhibition and Radiation Therapy in Lung Cancer. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
259
|
Luo XY, Yang MH, Peng P, Wu LJ, Liu QS, Chen L, Tang Z, Liu NT, Zeng XF, Liu Y, Yuan GH. Anti-erythropoietin receptor antibodies in systemic lupus erythematosus patients with anemia. Lupus 2012; 22:121-7. [PMID: 23080113 DOI: 10.1177/0961203312463980] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Anemia is a common hematologic abnormality in systemic lupus erythematosus (SLE). An inadequate erythropoietin (EPO) response in SLE patients with anemia has been described that may be due to the presence of antibodies to EPO in SLE patients. However, whether anemia in patients with SLE is related to antibodies to EPO receptor (EPOR) has not yet been investigated. We enlisted 169 consecutive patients with SLE and 45 normal individuals to investigate the existence and importance of circulating autoantibodies to EPOR in sera from patients with SLE. In all patients with SLE, the disease activity was evaluated by using the SLE disease activity index SLEDAI. Anti-EPOR antibodies were detected by using an enzyme-linked immunosorbent assay (ELISA). A higher frequency of anti-EPOR antibodies was observed in SLE patients than in healthy controls (18.3% vs 2.2%, p = 0.007). Moreover, anti-EPOR antibodies were detected in 22 of 69 (31.9%) SLE patients with anemia and in only nine of 100 (9.0%, p < 0.001) in those without. Furthermore, the patients with anti-EPOR antibodies exhibited more severe anemia and often presented as microcytic anemia (p = 0.001). Finally, anti-EPOR antibodies seemed more likely to occur in patients with rash (p = 0.008), lower levels of C(3) component (p = 0.01), higher titer of anti-dsDNA antibodies (p < 0.001) and higher disease activity scores (p = 0.024). The results of this study suggest that anti-EPOR antibodies might play a vital role in SLE patients developing anemia because of the higher incidence of antibodies to EPOR found in SLE patients with anemia. Thus, there might be clinical value in detecting anti-EPOR antibodies in SLE patients with anemia. Therefore, the pathologic role of the antibodies in inducing anemia needs to be established in future studies.
Collapse
|
260
|
Qin L, Tang Z, Liu K, Ye S, Zhou G. P53 mutations may be related to tumor invasiveness of human hepatocellular-carcinoma in china. Oncol Rep 2012; 2:1175-9. [PMID: 21597878 DOI: 10.3892/or.2.6.1175] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
A combined polymerase chain reaction (PCR) with the enzyme HaeIII restriction analysis and DNA sequencing have been employed to study the mutations at codon 249 of p53 gene in two human hepatocellular carcinoma (HCC) cell lines and 28 surgical specimens of HCC. 14 of the 28 HCC samples (50%) had p53 point mutations at codon 249. All of point mutations at codon 249 in 10 cases sequenced are AGG to AGT transversion. p53 gene mutated more frequently in invasive HCCs than that in non-invasive HCCs. This suggested that the codon 249 was a mutational hotspot of p53 gene in human HCCs in China, and p53 mutations may be related to tumor invasiveness of human HCC.
Collapse
|
261
|
Liao Y, Tang Z, Liu K, Ye S, Li J, Huang Z, Wang D, Segal D. Preparation and application of anti-HBx/anti-CD3 bispecific monoclonal antibody (BsAb) retargeting effector cells for lysis of human hepatoma xenografts in nude mice. Oncol Rep 2012; 3:637-44. [PMID: 21594426 DOI: 10.3892/or.3.4.637] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Evidence indicated that the x gene of human HBV can cause cancer in transgenic mice, moreover, HBxAg was so far the most frequent and strong antigen among those HBV markers expressed in hepatocellular carcinoma (HCC) tissues. Aiming to enhance killing of HCC by effector cells, we established an anti-HBx/anti-CD3 hybrid-hybridomas by fusion of anti-HBx hybridoma cells with FITC-labeled anti-CD3 HAT sensitive cells, and followed by FACStar sterile cell sorting, HAT selection and eventually verified by ELISA and double bridging assay. Using two color cytometric analysis, we found that bispecific monoclonal antibody (BsAb) remarkably enhanced in vitro effector-target cell conjugates (48.3% vs. 8.5%). In in vivo study, BsAb retargeting effector cells were significantly more effective than that of effector cells alone in shrinkage of LTNM4 HCC xenografts (HBxAg positive) in nude mice, not only in fresh inoculated tumors but also in established tumors (p<0.01, p<0.01, respectively). Besides, pronounced apoptotic cell death and infiltration of lymphocytes in the peripheral of tumor nodules can also be witnessed in the tissues treated by BsAb plus effector cells, but not in the controls. The results demonstrated that antiHBx/anti-CD3 BsAb was able to redirect effector cells for lysis of HBxAg positive HCC cells both in vitro and in vivo and it also indicated that shrinkage of tumors in nude mice with therapy of BsAb retargeting effector cells was partially due to initiation of apoptotic cell death.
Collapse
|
262
|
Proescholdt MA, Merrill MJ, Stoerr EM, Lohmeier A, Brawanski A, Sim H, Hu B, Pineda CA, Yoon SO, Viapiano MS, Rajappa P, Cobb WS, Huang Y, Lyden DC, Bromberg J, Greenfield JP, Li M, Mukasa A, Inda MDM, Zhang J, Chin L, Cavenee W, Furnari F, Zheng PP, van der Weiden M, van der Spek PJ, Vincent AJ, Kros JM, Fathallah-Shaykh HM, Saut O, Lagaert JB, Colin T, Fathallah-Shaykh HM, Araysi L, Tang Z, Duck KA, Ponnuru P, Neely EB, Connor JR, Esencay M, Gonzalez P, Gaziel A, Safraz Y, Mira H, Hernando E, Zagzag D, McDermott RA, Ulasov I, Kaverina N, Gabikian P, Lesniak M, Iranmahboob A, Haber M, Esencay M, Fatterpekar G, Raz E, Placantonakis D, Zagzag D, Eoli M, Rabascio C, Cuppini L, Anghileri E, Pellegatta S, Calleri A, Mancuso P, Porrati P, Bertolini F, Finocchiaro G, Seals DF, Burger KL, Gibo DM, Debinski W, Esencay M, Zagzag D, Tran NL, Tuncali S, Kloss J, Yang Z, Schumacher CA, Diegel C, Ross JT, Williams BO, Eschbacher JM, Loftus JC, Whiteman M, Dombovy-Johnson M, Vangellow A, Liu Y, Carson-Walter E, Walter KA, Liu Y, Carson-Walter E, Walter K, Cortes-Santiago N, Gabrusiewicz K, Liu D, Hossain MB, Gumin J, Fan X, Conrad C, Aldape K, Gilbert M, Raghunathan A, Yung WKA, Fueyo J, Gomez-Manzano C, Bae E, Huang P, Burgett M, Muller-Greven G, Kar N, Gladson CL, Engler JR, Robinson AE, Molinaro A, Phillips JJ, Zadeh G, Burrell K, Hill R, Piao Y, Liang J, Henry V, Holmes L, Sulman E, deGroot JF, Piao Y, Liang J, Henry V, Holmes L, de Groot JF, Rong W, Funato K, Georgala P, Shimizu F, Droms L, Tabar V, Parker JJ, Dionne KR, Massarwa R, Klaassen M, Foreman NK, Niswander L, Canoll P, Kleinschmidt-DeMasters BK, Waziri A. LAB-ANGIOGENESIS AND INVASION. Neuro Oncol 2012. [DOI: 10.1093/neuonc/nos219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
263
|
Fang X, Shi J, Song X, Mitnitski A, Tang Z, Wang C, Yu P, Rockwood K. Frailty in relation to the risk of falls, fractures, and mortality in older Chinese adults: results from the Beijing Longitudinal Study of Aging. J Nutr Health Aging 2012; 16:903-7. [PMID: 23208030 DOI: 10.1007/s12603-012-0368-6] [Citation(s) in RCA: 83] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
OBJECTIVES Falls are well known to be associated with adverse health outcomes, especially when complicated by fracture. Falls are more common in people who are frail and readily related to several items in the frailty phenotype. Less is known about the relationship between falls and frailty defined as deficit accumulation. Our objective was to investigate the relationship between falls, fractures, and frailty based on deficit accumulation. DESIGN Representative cohort study, with 8 year follow-up. SETTING The Beijing Longitudinal Study of Aging (BLSA). PARTICIPANTS 3,257 Chinese people aged 55+ years at baseline. MEASUREMENTS A frailty index (FI) was constructed using 33 health deficits, but excluding falls and fractures. The rates of falls, fractures and death as a function of age and the FI were analyzed. Multivariable models evaluated the relationships between frailty and the risk of recurrent falls, fractures, and mortality adjusting for age, sex, and education. Self or informant reported fall and fracture data were verified against participants' health records. RESULTS Of 3,257 participants at baseline (1992), 360 people (11.1%) reported a history of falls, and 238 (7.3%) reported fractures. By eight years, 1,155 people had died (35.3%). The FI was associated with an increased risk of recurrent falls (OR=1.54; 95% confidence interval (CI)=1.34-1.76), fractures (OR=1.07; 95% CI=0.94-1.22), and death (OR=1.50, 95% CI=1.41-1.60). The FI showed a significant effect on mortality in a multivariate Cox regression model (Hazard Rate=1.29, 95% CI=1.25-1.33). When adjusted for the FI, neither falls nor fractures were associated with mortality. CONCLUSION Falls and fractures were common in older Chinese adults, and associated with frailty. Only frailty was independently associated with death.
Collapse
|
264
|
Adamczyk L, Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Aschenauer E, Averichev GS, Balewski J, Bannerjee A, Barnovska Z, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bordyuzhin IG, Borowski W, Bouchet J, Brandin AV, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Butterworth J, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Chwastowski J, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derradi de Souza R, Dhamija S, Didenko L, Ding F, Dion A, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Eun L, Evdokimov O, Fatemi R, Fazio S, Fedorisin J, Fersch RG, Filip P, Finch E, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Gliske S, Gorbunov YN, Grebenyuk OG, Grosnick D, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Horvat S, Huang B, Huang HZ, Huck P, Humanic TJ, Huo L, Igo G, Jacobs WW, Jena C, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kesich A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Luo X, Luszczak A, Ma GL, Ma YG, Madagodagettige Don DMMD, Mahapatra DP, Majka R, Mall OI, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Morozov B, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nogach LV, Novak J, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Ostrowski P, Pachr M, Page BS, Pal SK, Pan YX, Pandit Y, Panebratsev Y, Pawlak T, Pawlik B, Pei H, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Powell CB, Prindle D, Pruneau C, Pruthi NK, Przybycien M, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Riley CK, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ross JF, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandacz A, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmidke B, Schmitz N, Schuster TR, Seele J, Seger J, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma B, Sharma M, Shi SS, Shou QY, Sichtermann EP, Singaraju RN, Skoby MJ, Smirnov D, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Turnau J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Vossen A, Wada M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xin K, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yi Y, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Transverse single-spin asymmetry and cross section forπ0andηmesons at large Feynmanxinp↑+pcollisions ats=200 GeV. Int J Clin Exp Med 2012. [DOI: 10.1103/physrevd.86.051101] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
265
|
Wang C, Song X, Mitnitski A, Yu P, Fang X, Tang Z, Shi J, Rockwood K. Gender Differences in the Relationship Between Smoking and Frailty: Results From the Beijing Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci 2012; 68:338-46. [DOI: 10.1093/gerona/gls166] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
266
|
Adamczyk L, Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Banerjee A, Barnovska Z, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Brandin AV, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Butterworth J, Cai XZ, Caines H, Calderón de la Barca Sánchez M, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Chwastowski J, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Davila Leyva A, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derradi de Souza R, Dhamija S, Didenko L, Ding F, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunkelberger LE, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Eun L, Evdokimov O, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Gliske S, Gorbunov YN, Grebenyuk OG, Grosnick D, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Horvat S, Huang B, Huang HZ, Huck P, Humanic TJ, Huo L, Igo G, Jacobs WW, Jena C, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kesich A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Luo X, Luszczak A, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Morozov B, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nogach LV, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pan YX, Pandit Y, Panebratsev Y, Pawlak T, Pawlik B, Pei H, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Powell CB, Prindle D, Pruneau C, Pruthi NK, Przybycien M, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Riley CK, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma B, Sharma M, Shi SS, Shou QY, Sichtermann EP, Singaraju RN, Skoby MJ, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, Szanto de Toledo A, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Turnau J, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Vossen A, Wada M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xin K, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yi Y, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Directed flow of identified particles in Au+Au collisions at √[SNN]=200 GeV at RHIC. PHYSICAL REVIEW LETTERS 2012; 108:202301. [PMID: 23003142 DOI: 10.1103/physrevlett.108.202301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/16/2011] [Indexed: 06/01/2023]
Abstract
STAR's measurements of directed flow (v1) around midrapidity for π±, K±, KS0, p, and p[over ¯] in Au+Au collisions at √[sNN]=200 GeV are presented. A negative v1(y) slope is observed for most of produced particles (π±, K±, KS0, and p[over ¯]). In 5%-30% central collisions, a sizable difference is present between the v1(y) slope of protons and antiprotons, with the former being consistent with zero within errors. The v1 excitation function is presented. Comparisons to model calculations (RQMD, UrQMD, AMPT, QGSM with parton recombination, and a hydrodynamics model with a tilted source) are made. For those models which have calculations of v1 for both pions and protons, none of them can describe v1(y) for pions and protons simultaneously. The hydrodynamics model with a tilted source as currently implemented cannot explain the centrality dependence of the difference between the v1(y) slopes of protons and antiprotons.
Collapse
|
267
|
Szotowska M, Chudek J, Wiecek A, Adamczak M, Bossola M, DI Stasio E, Antocicco M, Silvestri P, Tazza L, Stec A, Koziol - Montewka M, Ksiazek A, Birnie K, Caskey F, Geeson AI, Dairaghi D, Johnson D, Leleti M, Miao S, Xiao H, Jennette JC, Powers JP, Seitz L, Wang Y, Jaen JC, Schall TJ, Bekker P, Arai H, Hayashi H, Sugiyama K, Yamamoto K, Koide S, Murakami K, Tomita M, Hasegawa M, Yuzawa Y, Karasavvidou D, Karasavvidou D, Kalaitzidis R, Spanos G, Pappas K, Tatsioni A, Siamopoulos K, Zhang YY, Tang Z, Chen DM, Zhang MC, Liu ZH, Milovanov Y, Milovanova L, Kozlovskaya L, Klein C, Noertersheuser P, Mensing S, Teuscher N, Meyer C, Dumas E, Awni W, Dezfoolian H, Samuelsson O, Svensson M, Yasuda Y, Kato S, Tsuboi N, Sato W, Maruyama S, Imai E, Yuzawa Y, Matsuo S, Sarafidis P, Blacklock R, Wood E, Rumjon A, Simmonds S, Fletcher-Rogers J, Elias R, Tucker B, Baynes D, Sharpe C, Vinen K, Hebbar S, Goldsberry A, Chin M, Meyer C, Audhya P. Clinical studies in CKD 1-5. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
268
|
Xu Y, Bao Q, He B, Pan Y, Zhang R, Mao X, Tang Z, Qu L, Zhu C, Tian F, Wang S. Association of angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensin I converting enzyme 2 gene polymorphisms with the dyslipidemia in type 2 diabetic patients of Chinese Han origin. J Endocrinol Invest 2012; 35:378-83. [PMID: 21670585 DOI: 10.3275/7797] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
OBJECTIVE To investigate whether the genetic polymorphisms in the angiotensin I converting enzyme (ACE) (insertion/ deletion, or I/D), angiotensin II type 1 receptor (AT1R) (rs5186), and ACE2 (rs2285666) could be associated with dyslipidemia in Type 2 diabetic (T2D) patients of Chinese Han origin. DESIGN AND METHODS The above 3 polymorphisms were genotyped in a total of 282 patients with T2D and dyslipidemia (Group A), 182 patients with T2D but without dyslipidemia (Group B), and 324 healthy controls. The association between a certain polymorphism and each group was assessed by an odds ratio (OR). RESULTS The D allele of the ACE (I/D) was significantly associated with the risk of T2D accompanying dyslipidemia between group A and controls [OR=1.37, 95% confidence interval (CI)=1.08-1.74; p=0.010], and significant association of the D allele with dyslipidemia was also observed in diabetic patients (OR=1.88, 95% CI=1.40-2.54; p<0.001). Furthermore, the ID genotype had a decreased risk of developing T2D without dyslipidemia as compared with controls (OR=0.52, 95% CI=0.32-0.82; p=0.0060). The distributions of the AT1R (rs5186) and ACE2 (rs2285666) genotypes and alleles did not differ between T2D patients with or without dyslipidemia and the controls. CONCLUSIONS This study demonstrates that the ACE (I/D) polymorphism is associated with T2D, regardless of the absence or presence of dyslipidemia. The polymorphisms in the AT1R (rs5186) and ACE2 (rs2285666) seem to play lesser roles in the development of T2D.
Collapse
|
269
|
Patel J, Kittleson M, Rafiei M, Stern L, Tang Z, Chang D, Luthringer D, Czer L, Trento A, Kobashigawa J. 683 The Natural History of Biopsy Negative Rejection after Heart Transplantation. J Heart Lung Transplant 2012. [DOI: 10.1016/j.healun.2012.01.698] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
270
|
Cao H, Qi Z, Jiang H, Zhao J, Liu Z, Tang Z. Detection of Porphyromonas endodontalis, Porphyromonas gingivalis and Prevotella intermedia in primary endodontic infections in a Chinese population. Int Endod J 2012; 45:773-81. [DOI: 10.1111/j.1365-2591.2012.02035.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
271
|
Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Barnby LS, Beavis DR, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Braidot E, Brandin AV, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Sánchez MCDLB, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Christie W, Chung P, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Leyva AD, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derevschikov AA, de Souza RD, Didenko L, Djawotho P, Dong X, Drachenberg JL, Draper JE, Du CM, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Estienne M, Eun L, Evdokimov O, Fachini P, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk OG, Grosnick D, Gupta A, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heppelmann S, Hirsch A, Hoffmann GW, Hofman DJ, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Jacobs WW, Jena C, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kravtsov P, Krueger K, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Lukashov EV, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nasim M, Nayak TK, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Pei H, Peitzmann T, Perkins C, Peryt W, Pile P, Planinic M, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma M, Shi SS, Shou QY, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, de Toledo AS, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhan W, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Identified hadron compositions in p+p and Au+Au collisions at high transverse momenta at √S(NN)=200 GeV. PHYSICAL REVIEW LETTERS 2012; 108:072302. [PMID: 22401197 DOI: 10.1103/physrevlett.108.072302] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/04/2011] [Indexed: 05/31/2023]
Abstract
We report transverse momentum (p(T)≤15 GeV/c) spectra of π(±), K(±), p, p[over ¯], K(S)(0), and ρ(0) at midrapidity in p+p and Au+Au collisions at √S(NN)=200 GeV. Perturbative QCD calculations are consistent with π(±) spectra in p+p collisions but do not reproduce K and p(p[over ¯]) spectra. The observed decreasing antiparticle-to-particle ratios with increasing p(T) provide experimental evidence for varying quark and gluon jet contributions to high-p(T) hadron yields. The relative hadron abundances in Au+Au at p(T)≳8 GeV/c are measured to be similar to the p+p results, despite the expected Casimir effect for parton energy loss.
Collapse
|
272
|
Agakishiev G, Aggarwal MM, Ahammed Z, Alakhverdyants AV, Alekseev I, Alford J, Anderson BD, Anson CD, Arkhipkin D, Averichev GS, Balewski J, Barnby LS, Beavis DR, Behera NK, Bellwied R, Betancourt MJ, Betts RR, Bhasin A, Bhati AK, Bichsel H, Bielcik J, Bielcikova J, Bland LC, Bordyuzhin IG, Borowski W, Bouchet J, Braidot E, Brandin AV, Bridgeman A, Brovko SG, Bruna E, Bueltmann S, Bunzarov I, Burton TP, Cai XZ, Caines H, Sánchez MCDLB, Cebra D, Cendejas R, Cervantes MC, Chaloupka P, Chattopadhyay S, Chen HF, Chen JH, Chen JY, Chen L, Cheng J, Cherney M, Chikanian A, Choi KE, Christie W, Chung P, Codrington MJM, Corliss R, Cramer JG, Crawford HJ, Cui X, Leyva AD, De Silva LC, Debbe RR, Dedovich TG, Deng J, Derevschikov AA, de Souza RD, Didenko L, Djawotho P, Dogra SM, Dong X, Drachenberg JL, Draper JE, Du CM, Dunlop JC, Efimov LG, Elnimr M, Engelage J, Eppley G, Estienne M, Eun L, Evdokimov O, Fatemi R, Fedorisin J, Fersch RG, Filip P, Finch E, Fine V, Fisyak Y, Gagliardi CA, Gangadharan DR, Geurts F, Ghosh P, Gorbunov YN, Gordon A, Grebenyuk OG, Grosnick D, Gupta A, Gupta S, Guryn W, Haag B, Hajkova O, Hamed A, Han LX, Harris JW, Hays-Wehle JP, Heinz M, Heppelmann S, Hirsch A, Hjort E, Hoffmann GW, Hofman DJ, Huang B, Huang HZ, Humanic TJ, Huo L, Igo G, Jacobs P, Jacobs WW, Jena C, Jin F, Jones PG, Joseph J, Judd EG, Kabana S, Kang K, Kapitan J, Kauder K, Ke HW, Keane D, Kechechyan A, Kettler D, Kikola DP, Kiryluk J, Kisiel A, Kizka V, Klein SR, Knospe AG, Koetke DD, Kollegger T, Konzer J, Koralt I, Koroleva L, Korsch W, Kotchenda L, Kouchpil V, Kravtsov P, Krueger K, Krus M, Kumar L, Lamont MAC, Landgraf JM, LaPointe S, Lauret J, Lebedev A, Lednicky R, Lee JH, Leight W, LeVine MJ, Li C, Li L, Li N, Li W, Li X, Li X, Li Y, Li ZM, Lima LM, Lisa MA, Liu F, Liu H, Liu J, Ljubicic T, Llope WJ, Longacre RS, Lu Y, Lukashov EV, Luo X, Ma GL, Ma YG, Mahapatra DP, Majka R, Mall OI, Manweiler R, Margetis S, Markert C, Masui H, Matis HS, McDonald D, McShane TS, Meschanin A, Milner R, Minaev NG, Mioduszewski S, Mitrovski MK, Mohammed Y, Mohanty B, Mondal MM, Morozov B, Morozov DA, Munhoz MG, Mustafa MK, Naglis M, Nandi BK, Nayak TK, Nelson JM, Nogach LV, Nurushev SB, Odyniec G, Ogawa A, Oh K, Ohlson A, Okorokov V, Oldag EW, Oliveira RAN, Olson D, Pachr M, Page BS, Pal SK, Pandit Y, Panebratsev Y, Pawlak T, Pei H, Peitzmann T, Perkins C, Peryt W, Pile P, Planinic M, Ploskon MA, Pluta J, Plyku D, Poljak N, Porter J, Poskanzer AM, Potukuchi BVKS, Powell CB, Prindle D, Pruneau C, Pruthi NK, Pujahari PR, Putschke J, Qiu H, Raniwala R, Raniwala S, Ray RL, Redwine R, Reed R, Ritter HG, Roberts JB, Rogachevskiy OV, Romero JL, Ruan L, Rusnak J, Sahoo NR, Sakrejda I, Salur S, Sandweiss J, Sangaline E, Sarkar A, Schambach J, Scharenberg RP, Schaub J, Schmah AM, Schmitz N, Schuster TR, Seele J, Seger J, Selyuzhenkov I, Seyboth P, Shah N, Shahaliev E, Shao M, Sharma M, Shi SS, Shou QY, Sichtermann EP, Simon F, Singaraju RN, Skoby MJ, Smirnov N, Solanki D, Sorensen P, deSouza UG, Spinka HM, Srivastava B, Stanislaus TDS, Steadman SG, Stevens JR, Stock R, Strikhanov M, Stringfellow B, Suaide AAP, Suarez MC, Subba NL, Sumbera M, Sun XM, Sun Y, Sun Z, Surrow B, Svirida DN, Symons TJM, de Toledo AS, Takahashi J, Tang AH, Tang Z, Tarini LH, Tarnowsky T, Thein D, Thomas JH, Tian J, Timmins AR, Tlusty D, Tokarev M, Trainor TA, Trentalange S, Tribble RE, Tribedy P, Trzeciak BA, Tsai OD, Ullrich T, Underwood DG, Van Buren G, van Nieuwenhuizen G, Vanfossen JA, Varma R, Vasconcelos GMS, Vasiliev AN, Videbæk F, Viyogi YP, Vokal S, Voloshin SA, Wada M, Walker M, Wang F, Wang G, Wang H, Wang JS, Wang Q, Wang XL, Wang Y, Webb G, Webb JC, Westfall GD, Whitten C, Wieman H, Wissink SW, Witt R, Witzke W, Wu YF, Xiao Z, Xie W, Xu H, Xu N, Xu QH, Xu W, Xu Y, Xu Z, Xue L, Yang Y, Yang Y, Yepes P, Yip K, Yoo IK, Zawisza M, Zbroszczyk H, Zhan W, Zhang JB, Zhang S, Zhang WM, Zhang XP, Zhang Y, Zhang ZP, Zhao F, Zhao J, Zhong C, Zhu X, Zhu YH, Zoulkarneeva Y. Strangeness enhancement in Cu-Cu and Au-Au collisions at √S(NN)=200 GeV. PHYSICAL REVIEW LETTERS 2012; 108:072301. [PMID: 22401196 DOI: 10.1103/physrevlett.108.072301] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/15/2011] [Indexed: 05/31/2023]
Abstract
We report new STAR measurements of midrapidity yields for the Λ, Λ[over ¯], K(S)(0), Ξ(-), Ξ[over ¯](+), Ω(-), Ω[over ¯](+) particles in Cu+Cu collisions at √S(NN)==200 GeV, and midrapidity yields for the Λ, Λ[over ¯], K(S)(0) particles in Au+Au at √S(NN)==200 GeV. We show that, at a given number of participating nucleons, the production of strange hadrons is higher in Cu+Cu collisions than in Au+Au collisions at the same center-of-mass energy. We find that aspects of the enhancement factors for all particles can be described by a parametrization based on the fraction of participants that undergo multiple collisions.
Collapse
|
273
|
Luo Y, Jiang W, Da Z, Wang B, Hu L, Zhang Y, An R, Yu H, Sun H, Tang K, Tang Z, Wang Y, Jing T, Zhu B. Subunit Vaccine Candidate AMM Down-Regulated the Regulatory T Cells and Enhanced the Protective Immunity of BCG on a Suitable Schedule. Scand J Immunol 2012; 75:293-300. [DOI: 10.1111/j.1365-3083.2011.02666.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
274
|
Miller JH, Wijesinghe AI, Tang Z, Guloy AM. Correlated quantum transport of density wave electrons. PHYSICAL REVIEW LETTERS 2012; 108:036404. [PMID: 22400766 DOI: 10.1103/physrevlett.108.036404] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/20/2011] [Indexed: 05/31/2023]
Abstract
Recently observed Aharonov-Bohm quantum interference of the period h/2e in charge density wave rings strongly suggests that correlated density wave electron transport is a cooperative quantum phenomenon. The picture discussed here posits that quantum solitons nucleate and transport current above a Coulomb blockade threshold field. We propose a field-dependent tunneling matrix element and use the Schrödinger equation, viewed as an emergent classical equation as in Feynman's treatment of Josephson tunneling, to compute the evolving macrostate amplitudes, finding excellent quantitative agreement with voltage oscillations and current-voltage characteristics in NbSe(3). A proposed phase diagram shows the conditions favoring soliton nucleation versus classical depinning.
Collapse
|
275
|
You Q, Jiang C, Wu Y, Yu X, Chen Y, Zhang X, Wei W, Wang Y, Tang Z, Jiang D, Wu Y, Wang C, Meng X, Zhao X, Kong W. Subcutaneous Administration of Modified Vaccinia Virus Ankara Expressing an Ag85B-ESAT6 Fusion Protein, but Not an Adenovirus-Based Vaccine, Protects Mice Against Intravenous Challenge with Mycobacterium tuberculosis. Scand J Immunol 2011; 75:77-84. [DOI: 10.1111/j.1365-3083.2011.02629.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
|